Marcela Valderrama Maus

Massachusetts General Hospital

NIH Rank #2186
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$3.3M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#2,186
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.3M across 4 grants · National rank #2186.

Top grants by award amount

Marcela Valderrama Maus's NIH grant portfolio, ranked by award amount.

  • 5UG3CA283619-02UG3
    CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer
    $1.3M
    award amount
  • 5R01CA249062-04R01
    Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
    $668K
    award amount
  • 5R01CA252940-05R01
    Efficacy and immune effects of anakinra prophylaxis for neurologic toxicity and cytokine release syndrome in patients with lymphoma receiving axicabtagene ciloleucel
    $662.3K
    award amount
  • 1R01CA294071-01A1R01
    Bioactivity of CAR T cells secreting T cell engager-anitbodies in humans with glioblastoma
    $652.7K
    award amount

Affiliation

Institutions that have administered grants for Marcela Valderrama Maus.

Affiliated with Massachusetts General Hospital (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2186
  6. 2024
    Entered Top 25% Nationally
    Ranked #2186